Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
Sophia Zoungas(University of Sydney), Mark Woodward(UNSW Sydney), Diederick E. Grobbee(University Medical Center Utrecht), Laurent Billot(The George Institute for Global Health), David R. Matthews(Manchester College), Anthony Rodgers(The George Institute for Global Health), Bryan Williams(The London College), Helen Monaghan(The George Institute for Global Health), Pavel Hamet(Centre Hospitalier de l’Université de Montréal), Stephen MacMahon, Vlado Perkovic(New South Wales Department of Health), Stephen Harrap(The Royal Melbourne Hospital), Rohina Joshi(UNSW Sydney), Simon Heller(University of Sheffield), John Chalmers(UNSW Sydney), Mark E. Cooper(Australian Regenerative Medicine Institute), Neil R Poulter(Imperial College London), Bruce Neal(UNSW Sydney), Stephen Colagiuri(The University of Sydney), Giuseppe Mancia(University of Milano-Bicocca), Anushka Patel(UNSW Sydney), Hisatomi Arima(University of Leicester), Michel Marre(Centre National de la Recherche Scientifique), Qiang Li(Fuzhou University), Paul Glasziou(Bond University), Carl Erik Mogensen(Aarhus University Hospital), Yoichiro Hirakawa(University of Leicester)
Cited by 624
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.4k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k